| Literature DB >> 21765955 |
Sylvain Losdat1, Heinz Richner, Jonathan D Blount, Fabrice Helfenstein.
Abstract
Mounting an immune response against pathogens incurs costs to organisms by its effects on important life-history traits, such as reproductive investment and survival. As shown recently, immune activation produces large amounts of reactive species and is suggested to induce oxidative stress. Sperm are highly susceptible to oxidative stress, which can negatively impact sperm function and ultimately male fertilizing efficiency. Here we address the question as to whether mounting an immune response affects sperm quality through the damaging effects of oxidative stress. It has been demonstrated recently in birds that carotenoid-based ornaments can be reliable signals of a male's ability to protect sperm from oxidative damage. In a full-factorial design, we immune-challenged great tit males while simultaneously increasing their vitamin E availability, and assessed the effect on sperm quality and oxidative damage. We conducted this experiment in a natural population and tested the males' response to the experimental treatment in relation to their carotenoid-based breast coloration, a condition-dependent trait. Immune activation induced a steeper decline in sperm swimming velocity, thus highlighting the potential costs of an induced immune response on sperm competitive ability and fertilizing efficiency. We found sperm oxidative damage to be negatively correlated with sperm swimming velocity. However, blood resistance to a free-radical attack (a measure of somatic antioxidant capacity) as well as plasma and sperm levels of oxidative damage (lipid peroxidation) remained unaffected, thus suggesting that the observed effect did not arise through oxidative stress. Towards the end of their breeding cycle, swimming velocity of sperm of more intensely colored males was higher, which has important implications for the evolution of mate choice and multiple mating in females because females may accrue both direct and indirect benefits by mating with males having better quality sperm.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21765955 PMCID: PMC3134482 DOI: 10.1371/journal.pone.0022221
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
REML-GLMM for repeated measures testing for a within-male effect of the immune challenge and the vitamin E-supplementation on mean sperm swimming velocity and mean percentage of motile sperm (means over the three measurement times) between day 7 and 13 post-hatch.
| Sperm swimming velocity | Percentage of motile sperm | |||||
| Effect | Estimate ± s.e |
|
| Estimate ± s.e |
|
|
| (Intercept) | 15.83±13.25 | - | - | 0.26±0.14 | - | - |
| Laying date | −0.05±0.19 | 0.081, 64 | 0.78 | 0.00±0.00 | 1.271, 64 | 0.26 |
|
|
|
|
| 0.02±0.03 | 0.851, 64 | 0.36 |
| Vitamin E supplementation | 2.84±3.35 | 0.721, 64 | 0.40 | −0.04±0.03 | 3.001, 64 | 0.09 |
|
|
|
|
| 0.00±0.03 | 0.011, 49 | 0.94 |
| Initial brood size | 0.48±0.67 | 0.521, 64 | 0.47 | 0.00±0.01 | 0.451, 64 | 0.51 |
| Breast color | 1.85±1.41 | 1.731, 64 | 0.19 | −0.01±0.01 | 0.441, 64 | 0.51 |
| Vitamin E supplementation | −4.32±3.62 | 1.421, 49 | 0.24 | 0.00±0.03 | 0.001, 49 | 0.96 |
| Immune Challenge | −4.92±3.76 | 1.711, 64 | 0.20 | −0.01±0.03 | 0.061, 64 | 0.81 |
| Immune Challenge | −6.36±3.63 | 3.061, 49 | 0.09 | 0.02±0.01 | 2.301, 49 | 0.13 |
| Immune Challenge | −1.64±1.24 | 1.771, 64 | 0.19 | 0.00±0.01 | 0.051, 64 | 0.83 |
| Vitamin E supplementation | −2.21±1.19 | 3.461, 64 | 0.07 | 0.00±0.01 | 0.171, 64 | 0.68 |
|
|
|
|
| 0.00±0.00 | 1.271, 49 | 0.26 |
Significant terms in the model are highlighted in bold.
Relative to the PBS-injected group.
Relative to the placebo group.
Relative to first capture on day 7.
REML-GLMM for repeated measures testing the effect of the immune challenge and the vitamin E-supplementation on dynamics of sperm velocity (measured 0, 60 and 120 seconds after ejaculation) on day 13 post-hatch.
| Sperm swimming velocity | Percentage of motile sperm | |||||
| Effect | Estimate ± s.e. |
|
| Estimate ± s.e |
|
|
| (Intercept) | 9.27±17.80 | - | - | 0.25±0.25 | - | - |
| Laying date | 0.18±0.26 | 0.471, 56 | 0.5 | 0.003±0.004 | 0.961, 56 | 0.33 |
| Immune Challenge | −0.41±4.10 | 0.011, 56 | 0.92 | −0.004±0.05 | 0.001, 56 | 0.94 |
| Vitamin E supplementation | 1.18±3.94 | 0.091, 56 | 0.77 | −0.06±0.06 | 1.31, 56 | 0.26 |
|
|
|
|
|
|
|
|
| Initial brood size | 1.11±0.91 | 1.491, 56 | 0.23 | 0.01±0.01 | 1.31, 56 | 0.26 |
|
|
| 7.071, 56 |
| 0.01±0.01 | 1.051, 56 | 0.31 |
| Immune Challenge | −1.54±5.00 | 0.091, 56 | 0.76 | 0.00±0.07 | 0.001, 56 | 0.99 |
| Time×Breast color | - | 0.32, 111 | 0.74 | - | 1.162, 111 | 0.32 |
|
| - | 3.232, 111 |
| - | 0.452, 111 | 0.64 |
| Time×Vitamin E supplementation | - | 2.222, 111 | 0.11 | - | 0.812, 111 | 0.45 |
Significant terms in the model are highlighted in bold.
Relative to the PBS-injected group.
Relative to the placebo group.
REML-GLMM for repeated measures testing for a within-male effect of the immune challenge and the vitamin E-supplementation on MDA levels in semen, MDA levels in plasma and KRL between day 7 and 13 post-hatch.
| MDA levels in sperm | MDA levels in plasma | KRL | |||||||
| Effect | Estimate ± se |
|
| Estimate ± s.e |
|
| Estimate ± s.e |
|
|
| (Intercept) | 3.53±0.94 | - | - | 1.34±0.64 | - | - | 1.96±1.12 | - | - |
| Laying date | −0.01±0.01 | 0.321, 62 | 0.58 | 0±0.01 | 0.171, 64 | 0.68 | 0±0.02 | 0.041, 60 | 0.84 |
| Vitamin E supplementation | −0.17±0.22 | 0.571, 62 | 0.45 | −0.07±0.15 | 0.221, 64 | 0.64 | −0.38±0.24 | 2.511, 60 | 0.12 |
|
| −0.1±0.22 | 0.221, 40 | 0.64 | −0.21±0.12 | 2.851, 40 | 0.10 |
|
|
|
| Immune Challenge | 0.01±0.23 | 0.001, 62 | 0.95 | 0.06±0.15 | 0.141, 64 | 0.71 | −0.2±0.24 | 0.651, 60 | 0.42 |
|
| 0.03±0.05 | 0.331, 62 | 0.57 |
|
|
| 0.05±0.05 | 1.061, 60 | 0.31 |
| Breast color | 0.07±0.06 | 1.411, 62 | 0.24 | 0.02±0.03 | 0.421, 64 | 0.52 | −0.04±0.06 | 0.441, 60 | 0.51 |
|
| −0.03±0.25 | 0.021, 40 | 0.89 | 0.02±0.13 | 0.031, 40 | 0.87 |
|
|
|
| Day | 0.01±0.25 | 0.001, 40 | 0.97 | 0.00±0.13 | 01, 40 | 0.98 | 0.04±0.29 | 0.021, 22 | 0.9 |
| Day | −0.15±0.08 | 3.531, 40 | 0.07 | −0.07±0.04 | 2.641, 40 | 0.11 | 0.02±0.09 | 0.041, 22 | 0.85 |
| Immune Ch. | −0.27±0.25 | 1.191, 62 | 0.28 | 0.1±0.18 | 0.31, 64 | 0.59 | 0.41±0.28 | 2.161, 60 | 0.15 |
Significant terms in the models are highlighted in bold.
Relative to the PBS-injected group.
Relative to the placebo group.
Relative to first capture on day 7.
Figure 1Sperm swimming velocity (mean ± se) in relation to the time after ejaculation and the immune challenge.
LPS-injected males: grey dots; PBS-injected males: black dots. Immune-challenged males showed significantly reduced sperm velocity two minutes after ejaculation (Tukey-adjusted post-hoc test: z = 2.74, p = 0.036).
Figure 2Sperm swimming velocity 13 days post-hatch in relation to plumage breast coloration (PCA scores).
The line is the linear regression line. Excluding the outlier from the analysis did not qualitatively change the results.
Figure 3Sperm swimming velocity on day 13 post-hatch in relation to levels of malondialdehyde (end-product of lipid peroxidation) in sperm.
The line is the linear regression line.